FARMACIA: Recent submissions
Now showing items 1-5 of 24
-
Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1. Ten Blanco, Marc; Flores, África; Pereda Pérez, Inmaculada; Piscitelli, Fabiana; Izquierdo Luengo, Cristina; Cristino, Luigia; Romero, Julián; Hillard, Cecilia J.; Maldonado, Rafael; Di Marzo, Vicenzo; Berrendero, Fernando (Biomedicine & Pharmacotherapy, 2022)
-
Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis. Rodríguez Cueto, Carmen; Gómez Almería, Marta; García Toscano, Laura; Romero, Julián; Hillard, Cecilia J.; De Lago, Eva; Fernández Ruiz, Javier (Brain Pathology, 2021)
-
Evaluation of the potential of total proanthocyanidin content in feces as an intake biomarker. Magdaleno Tapia, Cristina; Quifer Rada, Paola; Rodríguez Rodríguez, Elena; Estévez-Santiago, Rocío; L. Waterhouse, Andrew; Lamuela Reventós, Rosa M.; Olmedilla Alonso, Begoña; Pérez Jiménez, Jara (Food Research International, 2021)
-
New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence. Saravia, Rocío; Ten Blanco, Marc; Pereda Pérez, Inmaculada; Berrendero, Fernando (International Journal of Molecular Sciences, 2021)